参考文献:(上下滑动查看)
1.Pastma DF,Spitoni C et al. Cardiacevents after macrolides or fluoroquinolones in patients hospitalized forcommunity-acquired pneumonia: post-hoc analysis of a cluster-randomized trial[J].BMC Infect Dis.2019 ,19(1):17.
2.K Katapadi,G.Kostanyet al.A review of erythromycin-inducedmalignant tachyarrhythmia--torsade de pointes. A case report[J].Angiology.1997 ,48(9):821-6.
3.Cho Y,Park HS.Associationof oral ciprofloxacin,levofloxacin, ofloxacin and moxifloxacin with the risk ofserious ventricular arrhythmia: a nationwide cohort study in Korea[J].BMJ Open. 2018 ,8(9):e020974.
4.Falagas ME, Rafailidis PI,Rosmarakis ES.Arrhythmiasassociated with fluoroquinolone therapy[J].Int J Antimicrob Agents.2007Apr;29(4):374-9.
5.马满玲,刘璐.第2代抗组胺药物心脏毒性研究进展[J].中国药业.2005,14(4):75-76.
6.Kecspecméti V.Cardiaceffects of antipsychotics: mechanism of arrhythmias and sudden cardiacdeath[J]. Neuropsychopharmacol Hung. 2004 ,6(1):5-12.
7.Wu CS, Tsai YT, Tsai HJ. Antipsychotic drugsand the risk of ventricular arrhythmia and/or sudden cardiac death: anation-wide case-crossover study[J]. J Am Heart Assoc.2015,4(2):e001568.